Your browser doesn't support javascript.
loading
Photopharmacology of Protease Inhibitors: Current Status and Perspectives.
Coene, Jonathan; Wilms, Simon; Verhelst, Steven H L.
Affiliation
  • Coene J; Department of Cellular and Molecular Medicine, KU Leuven - University of Leuven, Herestraat 49, box 901b, 3000, Leuven, Belgium.
  • Wilms S; Department of Cellular and Molecular Medicine, KU Leuven - University of Leuven, Herestraat 49, box 901b, 3000, Leuven, Belgium.
  • Verhelst SHL; Department of Cellular and Molecular Medicine, KU Leuven - University of Leuven, Herestraat 49, box 901b, 3000, Leuven, Belgium.
Chemistry ; 30(22): e202303999, 2024 Apr 16.
Article in En | MEDLINE | ID: mdl-38224181
ABSTRACT
Proteases are involved in many essential biological processes. Dysregulation of their activity underlies a wide variety of human diseases. Photopharmacology, as applied on various classes of proteins, has the potential to assist protease research by enabling spatiotemporal control of protease activity. Moreover, it may be used to decrease side-effects of protease-targeting drugs. In this review, we discuss the current status of the chemical design of photoactivatable proteases inhibitors and their biological application. Additionally, we give insight into future possibilities for further development of this field of research.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Hydrolases / Protease Inhibitors Limits: Humans Language: En Journal: Chemistry Journal subject: QUIMICA Year: 2024 Type: Article Affiliation country: Belgium

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Hydrolases / Protease Inhibitors Limits: Humans Language: En Journal: Chemistry Journal subject: QUIMICA Year: 2024 Type: Article Affiliation country: Belgium